Colorectal Carcinoma — Trials

Colorectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,010 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 344
Recruiting: 194
Ph III recruiting: 12
Growth YoY: +2.3%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (127)

clinicaltrialsPublishedShowing 1,001–1,010 of 1,010 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00964457	Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients	unknown	Phase 2	60	Copenhagen University Hospital at HerlevOTHER	1	Aug 25, 2009	clinicaltrials
NCT00107861	Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases	completed	Phase 1 / Phase 2	44	BiogenINDUSTRY	1	Jul 14, 2009